INTRODUCTION
Agonist activation of all three opioid receptor subtypes ,u, a and K has been reported to result in the inhibition of adenylate cyclase and/or the regulation of ion channels by activation of one or more pertussis-toxin-sensitive guanine nucleotide-binding proteins (G-proteins) acting as signal transducers [1] . Although there has been extensive analysis of opioid receptor function and pharmacology, our understanding of the molecular basis of these properties is limited. All subtypes of opioid receptors have been recently cloned [2] [3] [4] . Comparison of amino acid sequences of the three cloned opioid receptors reveals high sequence similarity of the intracellular loops, suggesting that they might interact with similar G-proteins.
Reconstitution studies with the ,t opioid receptor solubilized from rat brain have indicated the potential of this receptor to interact with G, or G. [5] , whereas in NG108-15 hybrid cells the a opioid receptor appears to activate G12 [6] , Go [7] and possibly G13 [8] . Studies in neuronal cell lines and brain have noted that coupling of ,u opioid receptors to adenylate cyclase was maximally blocked by antibodies to Goa [9] . Using selective Gprotein antisera in native brain membranes, we have previously demonstrated that both the C-and N-terminal regions of Goa play a key role in opioid receptor-GO-protein interaction [10] .
Various laboratories have attempted to solubilize opioid receptors that retain binding characteristics similar to those in intact membranes. In most cases, occupancy of the receptor by a ligand before solubilization or high concentrations of NaCl were required for the receptor to display high-affinity guanine nucleotide-sensitive binding [11] [12] [13] [14] .
In the present study active opioid receptors from brain cortical membranes were solubilized with 10 mM CHAPS and immunoprecipitated with selective Goa-protein antisera. This allowed for the first time the observation of stable soluble , and a opioid receptor-GO-protein complexes derived from rat brain memdirected against the C-terminal decapeptide (OC2) Solubilization of membranes Rat brain cortical membranes were prepared as described by Georgoussi et al. [10] in the presence of 0.1 mM EGTA and 50 mM Tris/HCl, pH 7.5. Plasma membranes were diluted with buffer containing 50 mM Tris/HCl, pH 7.5, 50 jig/ml trypsin inhibitor and 0.1 mM phenylmethanesulphonyl fluoride (PMSF) (buffer A) and spun for 15 min at 165000g. The pellet was solubilized as described by Simonds et al. [11] in buffer A containing 10 mM CHAPS for 1 h at 4°C with gentle stirring. The solubilized preparation was centrifuged at 100000 g for 1 h at 4 'C. The clear supernatant was removed, diluted 10- 
Immunoprecipitatlon of oplold receptor-G-protein complexes
To immunoprecipitate opioid receptor-G-protein complexes, a sample of solubilized receptor (1 ml) was incubated with the appropriate G-protein antiserum (20 ,ul) under constant rotation at 4 'C. After 6 h, 100 ,ul of 50 % (w/v) Protein A-agarose beads was added to each sample and the mixture incubated overnight. Finally another portion of antiserum was added to bring the final antiserum dilution to 1: 30. These samples were incubated for a further 3-4 h and then centrifuged in an Eppendorf microcentrifuge for 2 min. The supernatant was removed, and the immune complex was washed by the addition of 1 ml of buffer B and re-centrifuged. The immunoprecipitate was resuspended in 1 
Immunological experiments
The generation and specificity of the antisera used in this study have been described extensively [10, 17, 18] . Crude antisera were chromatographed on Protein A-Sepharose (Sigma) as described previously [10] . After elution of the IgG fractions with 100 mM citric acid, pH 4.0, into 2 M Tris/HCl, pH 7.5, they were dialysed against 1O mM Tris/HCl, pH 7.5, containing 0.1 mM EDTA then lyophilized and reconstituted with the same buffer before use. Immunoblotting was performed [6] using horseradish peroxidase-linked donkey anti-rabbit IgG fraction as the secondary antibody. The conditions for gel electrophoresis and the transfer of protein to nitrocellulose membranes were as described previously [6] .
Statistical analysis
The results are expressed as means+ S.E.M.; statistical analysis was performed by Student's t test, accepting P < 0.05 as significant.
RESULTS

Solubilization of opioid receptor-G-protein complexes from rat cortical membranes with CHAPS
Active high-affinity opioid receptors were solubilized from brain cortical membranes with 10 mM CHAPS in the absence of NaCl as described by Simonds et al. [11] . Saturation these conditions 35 % of the total membrane-associated opioid receptor population could be detected in the solubilized preparation, indicating that either the remaining receptors were not solubilized or, more plausibly, they could not be detected in the soluble fraction by binding experiments [11, 13] .
The CHAPS extracts displayed high-affinity guanine nucleotide-sensitive agonist binding as assessed by displacement of Immunoprecipitation of solubilized rat cortical membranes with specific anti-G4c sera Anti-peptide sera IM 1, OC2 and ON I generated against peptides common to polypeptides corresponding to products from both the GoI and G02 splice variants of the Goa gene have been previously characterized [17] . Both antisera IM1 and OC2 were able to immunoprecipitate a 39 kDa polypeptide in the solubilized material which could be identified as Goa by immunoblotting with antiserum ONI (Figure 3 ). Antiserum ONI was also able to immunoprecipitate a 39 kDa polypeptide which was confirmed to be Goca by immunoblotting with antiserum OC2 (results not shown but see ref. [10] ). These results indicate that each of these antisera could bind G0a in the CHAPS extracts of rat cortical membranes, and therefore, if the opioid receptors were coupled to G0, it should be possible to co-immunoprecipitate the receptors using the Goa antisera. Antiserum OC2, which is directed against the C-terminal region of Goca, failed to immunoprecipitate specific [3H]diprenorphine-binding sites from the CHAPS extract when compared with a preimmune serum control (Table 1) . A similar lack of opioid receptor immunoprecipitation was observed with antiserum ONI which is directed against the N-terminal hexadecapeptide of isoforms of Goa (Table 1 
DISCUSSION
A widely used approach to assessing the specificity of receptor-Gprotein interactions has been to use anti-G-protein sera which are able to interfere with these interactions. This antibody approach has been extensively used to observe the interaction of a range of receptors with G-protein(s) [6, [18] [19] [20] . Using this method we have previously studied the interaction of rat brain cortex /t-opioid receptors with Go [10] .
Biochemical data supporting a physical association of opioid receptors and G-proteins and the nature of these interactions are limited. The work presented here describes an immunoprecipitation-based approach using a selective anti-peptide serum directed against amino acids 22-35 of forms of Goa (IM 1), which was shown to identify functional opioid receptor-G-protein interactions after solubilization of rat cortical membranes. Solubilization was carried out in the presence of 10 mM CHAPS as described by Simonds et al. [11] for the a opioid receptors present in NG108-15 hybrid cells, without altering the affinity of the receptor for diprenorphine (Figure 1) . Pretreatment of the solubilized preparation with GppNHp reduced the ability of DADLE to displace [3H]diprenorphine, indicating interaction between the receptor and a G-protein(s) (Figure 2 ). These observations demonstrate that the solubilization conditions used did not disrupt the association of the receptor with G-proteins and that occupancy of the receptor by a ligand before solubilization is not required to stabilize the receptor and the formation of receptor-G-protein complex.
The presence of tightly coupled opioid receptor-G-protein complexes in the absence of agonist has also been observed in digitonin-solubilized brain extracts [14] . Similar putative receptor-G-protein complexes have been reported after solubilization of the vasopressin [21] , the muscarinic acetylcholine [22] and D2-dopamine [23] It has been reported that the C-terminal region of Gcx plays a crucial role in receptor-G-protein intgraction and activation of the a-subunit after agonist binding to receptors [24] , whereas the N-terminal domain of G-protein is responsible for interaction of the a-subunit with fy-subunits [25] . The inability of antisera OC2 and ONI to immunoprecipitate soluble opioid receptor-Go complexes may be attributed to either uncoupling of the complexes by preventing the formation of the heterotrimer or recognition of these antisera by epitopes of Goa which are in direct contact with opioid receptors. Recent work has utilized antisera directed against the Cterminal region of Gil and G12 to immunoprecipitate somatostatin and ax2-adrenergic receptors with these G-proteins [26, 27] . Such studies might have been predicted to be ineffectual, as antisera of this type have been widely used to interfere with receptor signalling pathways [20, 29] . Although it has been assumed that such antisera uncouple G-proteins from their receptors, their effect may be to uncouple receptors and Gproteins only functionally rather than physically. In the present study we demonstrate that both ,u and a opioid receptors form stable complexes with one or more variants of Go.
The intracellular events mediated by these interactions remain to be clearly defined but, given the ability of both opioid receptors and the isoforms of Go to regulate voltage-operated Ca2l channels [30, 32] , this might represent an obvious target.
